4.8 Editorial Material

PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Targeting the phosphoinositide 3-kinase pathway in cancer

Pixu Liu et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Multidisciplinary Sciences

Knockin of mutant PIK3CA activates multiple oncogenic pathways

John P. Gustin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses

Federica Di Nicolantonio et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Oncology

Mutation of the PIK3CA oncogene in human cancers

B Karakas et al.

BRITISH JOURNAL OF CANCER (2006)